One reason is the low incidence of IDH-mutant LGG patients at a given medical center, and another reason is that IDH-mutant tumor cells are difficult to culture [196] or to grow as xenografts [7,197] and can undergo loss of the IDH1 mutation in vitro. Here, IDH2 is linked to neoplasm.